UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 5, 2021 4:01 P.M.
Form:
S-1
CIK:
0001811764
Company Name:
POINT Biopharma Global Inc.
File Number:
333-258325